Arzu Şenol
Research Subjects
Arzu Şenol has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Şafak Özer Balin
Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Fırat University, Elazıg 23000, Türkiye
5 shared publications - Zülal Aşçı Toraman
Department of Medical Microbiology, Faculty of Medicine, Firat University, Elazig, Turkey
4 shared publications - Feray Ferda Şenol
Department of Microbiology, Fethi Sekin City Hospital, Elazig, Turkey
2 shared publications - Pınar Öner
Fethi Sekin Şehir Hastanesi
2 shared publications - Özlem Aytaç
Department of Medical Microbiology, Elazığ Fethi Sekin City Hospital, Elazığ, Türkiye
2 shared publications Ali Yıldırım
1 shared publication
Latest Publications
- Open Access
- 27 March 2025
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 7 (1) , 58-65
Predictors for Publication of Specialty Theses in the Field of Infectious Diseases and Clinical Microbiology
The residency program of infectious diseases and clinical microbiology (IDCM) in Türkiye was started in 1983 by adopting the name IDCM. The IDCM program in Türkiye is a five-year program, including related clinical rotations. Presenting a thesis at the end of this program is mandatory. The first specialty thesis in the field of IDCM was
- 27 March 2025
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 7 (1) , 58-65
Open AccessPredictors for Publication of Specialty Theses in the Field of Infectious Diseases and Clinical Microbiology
The residency program of infectious diseases and clinical microbiology (IDCM) in Türkiye was started in 1983 by adopting the name IDCM. The IDCM program in Türkiye is a five-year program, including related clinical rotations. Presenting a thesis at the end of this program is mandatory. The first specialty thesis in the field of IDCM was
- Open Access
- 31 January 2024
- Published by Wiley
The importance of adiponectin gene polymorphisms in the stabilization of atherosclerotic plaques
Introduction: Some studies have indicated that adiponectin gene polymorphisms are related to coronary artery disease, and they play a role in the stabilization of atherosclerotic plaques. In this study, acute coronary artery disease patients who had a myocardial infarct with ST-elevation, chronic coronary artery disease patients who had a coronary artery bypass graft operation, and the control group with normal coronary arteries were compared for the adiponectin gene polymorphisms. Material and Methods: One hundred patients who had a myocardial infarction with ST-elevation (Group1), 100 patients who had a coronary artery bypass graft operation (Group2), and as the control group, 100 patients who had coronary angiography due to suspected coronary artery disease (CAD) and appeared to have normal coronary arteries (Group3) were included in the study. Adiponectin gene polymorphisms (rs 1501299; +276 G > T, rs2241766; +45 T > G) of the participants were determined using real-time polymerase chain reaction method. Results: The number of mutant GG base pairs of adiponectin at rs2241766 were smaller in Group 2 when compared to Group 1 and Group 3, and the difference was statistically significant (p=0.0001). Although the G allele frequencies of adiponectin at rs2241766 were similar in Groups 1 and 3 (p>0.05), the G allele frequencies in Group 2 were smaller when compared to Groups 1 and 3, and the difference was statistically significant (p=0.0001). The comparison of all groups for adiponectin rs1501299 polymorphisms and allele frequencies did not yield statistically significant results (p>0.05). Conclusion: Since adiponectin, which is thought to play a role in the stabilization of atherosclerotic plaques, has different genotype distributions and allele frequencies at rs2241766 in acute and chronic coronary artery disease, we suppose that this polymorphism can be interpreted as a risk factor.
- 31 January 2024
- Published by Wiley
Open AccessThe importance of adiponectin gene polymorphisms in the stabilization of atherosclerotic plaques
Introduction: Some studies have indicated that adiponectin gene polymorphisms are related to coronary artery disease, and they play a role in the stabilization of atherosclerotic plaques. In this study, acute coronary artery disease patients who had a myocardial infarct with ST-elevation, chronic coronary artery disease patients who had a coronary artery bypass graft operation, and the control group with normal coronary arteries were compared for the adiponectin gene polymorphisms. Material and Methods: One hundred patients who had a myocardial infarction with ST-elevation (Group1), 100 patients who had a coronary artery bypass graft operation (Group2), and as the control group, 100 patients who had coronary angiography due to suspected coronary artery disease (CAD) and appeared to have normal coronary arteries (Group3) were included in the study. Adiponectin gene polymorphisms (rs 1501299; +276 G > T, rs2241766; +45 T > G) of the participants were determined using real-time polymerase chain reaction method. Results: The number of mutant GG base pairs of adiponectin at rs2241766 were smaller in Group 2 when compared to Group 1 and Group 3, and the difference was statistically significant (p=0.0001). Although the G allele frequencies of adiponectin at rs2241766 were similar in Groups 1 and 3 (p>0.05), the G allele frequencies in Group 2 were smaller when compared to Groups 1 and 3, and the difference was statistically significant (p=0.0001). The comparison of all groups for adiponectin rs1501299 polymorphisms and allele frequencies did not yield statistically significant results (p>0.05). Conclusion: Since adiponectin, which is thought to play a role in the stabilization of atherosclerotic plaques, has different genotype distributions and allele frequencies at rs2241766 in acute and chronic coronary artery disease, we suppose that this polymorphism can be interpreted as a risk factor.
- Open Access
- 10 October 2023
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 48 (6) , 718-722
Fetuin A and fetuin B as an indicator of liver fibrosis in hepatitis B
Objectives: The aim of this study is to investigate the diagnostic and prognostic characteristics of fetuin A and fetuin B in chronic hepatitis B (CHB) and HBe Ag-negative chronic infection (HCI) and the relationship between the levels of these proteins and fibrosis in CHB. Methods: In this study, we examined 98 patients with CHB, 58 with HCI and 42 control groups. Fetuin A and B levels were determined via ELISA. Results: Serum fetuin A and B levels were significantly higher in the control group than the hepatitis B cases (p=0.001). No significant difference in fetuin A and B levels between patients in the CHB and HCI. In the CHB, fetuin A level was significantly lower in patients with significant fibrosis than those with mild fibrosis (p=0.007). Fetuin B was lower in patients with significant fibrosis than in with mild fibrosis; however, this difference was not significant. In predicting the absence of significant fibrosis, the area under the curve was estimated as 0.855 for fetuin A and 0.866 for fetuin B using the ROC curve. Conclusions: Fetuin A and B were lower in CHB and HCI compared to the control group and there was no difference between the two groups suggests that these proteins may be effective in the pathogenesis of hepatitis B-induced liver damage. Fetuin A and B, which are found to be lower in patients with significant fibrosis in CHB, can be used as non-invasive markers in the early detection of fibrosis and in the follow-up of progression to significant fibrosis.
- 10 October 2023
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 48 (6) , 718-722
Open AccessFetuin A and fetuin B as an indicator of liver fibrosis in hepatitis B
Objectives: The aim of this study is to investigate the diagnostic and prognostic characteristics of fetuin A and fetuin B in chronic hepatitis B (CHB) and HBe Ag-negative chronic infection (HCI) and the relationship between the levels of these proteins and fibrosis in CHB. Methods: In this study, we examined 98 patients with CHB, 58 with HCI and 42 control groups. Fetuin A and B levels were determined via ELISA. Results: Serum fetuin A and B levels were significantly higher in the control group than the hepatitis B cases (p=0.001). No significant difference in fetuin A and B levels between patients in the CHB and HCI. In the CHB, fetuin A level was significantly lower in patients with significant fibrosis than those with mild fibrosis (p=0.007). Fetuin B was lower in patients with significant fibrosis than in with mild fibrosis; however, this difference was not significant. In predicting the absence of significant fibrosis, the area under the curve was estimated as 0.855 for fetuin A and 0.866 for fetuin B using the ROC curve. Conclusions: Fetuin A and B were lower in CHB and HCI compared to the control group and there was no difference between the two groups suggests that these proteins may be effective in the pathogenesis of hepatitis B-induced liver damage. Fetuin A and B, which are found to be lower in patients with significant fibrosis in CHB, can be used as non-invasive markers in the early detection of fibrosis and in the follow-up of progression to significant fibrosis.
- Open Access
- 20 July 2023
- Published by Phoenix Medical Journal in Phoenix Medical Journal
Yara Örneklerinde Üreyen Etkenler ve Antibakteriyel Duyarlılık.
Amaç:Hastane kaynaklı enfeksiyonlar arasında yer alan yara enfeksiyonları az gelişmiş ve gelişmekte olan ülkeler için büyük bir sağlık sorunudur. Çalışmamızda yara enfeksiyonuna neden olan etkenler ve bu etkenlerin antibakteriyel duyarlılığının belirlenmesi amaçlanmıştır. Gereç ve Yöntem:1290 yara sürüntü örneği retrospektif olarak değerlendirildi. Etken olarak düşündüğümüz mikroorganizmaların tür düzeyinde tanımlanmaları ve antibakteriyel duyarlılıkları konvansiyoner ve VITEK-2 otomatize sistem ile çalışıldı. Bulgular:Örneklerin 505’inde bakteriyel, 16’sında mantarlar etken olarak izole edildi. İzole edilen bakteriyel etkenlerin; %60’ını Gram negatif bakteriler, %40’ını Gram pozitif bakteriler oluşturuyordu. Bakteriyel etkenler içinde en sık izole edilen bakteri 143 (%28.31) örnekle Staphylococcus aureus (S.aureus) bunu 121 (%24) örnekle Escherichia coli (E. coli), 47 (%9.30) örnekle Acinetobacter baumannii (A. baumanii), 46 (%9.10) örnekle Pseudomonas aeruginosa (P. aeruginosa) takip etti. Bu mikroorganizmaların en sık izole edildikleri servislere göre dağılımı ise S.aureus polikliniklerden, E.coli ve P.aeruginosa yatan hasta servislerinden, A. Baumanii yoğun bakım ünitelerinden saptandı. S.aureus’ların 61 (%42.65)’i metisiline dirençli bulunurken tigesiklin, vankomicin ve linezolid’e direnç saptanmadı. E.coli’ ye karşı en dirençli antibakteriyel ampisilin 111 (%91.73) hasta, en duyarlı antibakteriyel imipenem ve meropenem 118 (%97.52) hasta olarak saptandı. A. Baumanii’ye karşı antibakteriyellerin hepsinde yüksek direnç saptanırken kolistine karşı direnç saptanmadı. P. aeruginosa’ya karşı en dirençli antibakteriyel sefepim ve imipenem 14 (%29.78) hasta da saptanırken kolistine karşı direnç saptanmadı. Sonuç:İzole edilen mikroorganizmaların ve antibiyotik duyarlılıklarının bilinmesi, ampirik tedavilere yön verebilmek, hekimlerin kontrollü ve akılcı antibiyotik kullanımı konusunda bilinçlenmesini sağlayacaktır
- 20 July 2023
- Published by Phoenix Medical Journal in Phoenix Medical Journal
Open AccessYara Örneklerinde Üreyen Etkenler ve Antibakteriyel Duyarlılık.
Amaç:Hastane kaynaklı enfeksiyonlar arasında yer alan yara enfeksiyonları az gelişmiş ve gelişmekte olan ülkeler için büyük bir sağlık sorunudur. Çalışmamızda yara enfeksiyonuna neden olan etkenler ve bu etkenlerin antibakteriyel duyarlılığının belirlenmesi amaçlanmıştır. Gereç ve Yöntem:1290 yara sürüntü örneği retrospektif olarak değerlendirildi. Etken olarak düşündüğümüz mikroorganizmaların tür düzeyinde tanımlanmaları ve antibakteriyel duyarlılıkları konvansiyoner ve VITEK-2 otomatize sistem ile çalışıldı. Bulgular:Örneklerin 505’inde bakteriyel, 16’sında mantarlar etken olarak izole edildi. İzole edilen bakteriyel etkenlerin; %60’ını Gram negatif bakteriler, %40’ını Gram pozitif bakteriler oluşturuyordu. Bakteriyel etkenler içinde en sık izole edilen bakteri 143 (%28.31) örnekle Staphylococcus aureus (S.aureus) bunu 121 (%24) örnekle Escherichia coli (E. coli), 47 (%9.30) örnekle Acinetobacter baumannii (A. baumanii), 46 (%9.10) örnekle Pseudomonas aeruginosa (P. aeruginosa) takip etti. Bu mikroorganizmaların en sık izole edildikleri servislere göre dağılımı ise S.aureus polikliniklerden, E.coli ve P.aeruginosa yatan hasta servislerinden, A. Baumanii yoğun bakım ünitelerinden saptandı. S.aureus’ların 61 (%42.65)’i metisiline dirençli bulunurken tigesiklin, vankomicin ve linezolid’e direnç saptanmadı. E.coli’ ye karşı en dirençli antibakteriyel ampisilin 111 (%91.73) hasta, en duyarlı antibakteriyel imipenem ve meropenem 118 (%97.52) hasta olarak saptandı. A. Baumanii’ye karşı antibakteriyellerin hepsinde yüksek direnç saptanırken kolistine karşı direnç saptanmadı. P. aeruginosa’ya karşı en dirençli antibakteriyel sefepim ve imipenem 14 (%29.78) hasta da saptanırken kolistine karşı direnç saptanmadı. Sonuç:İzole edilen mikroorganizmaların ve antibiyotik duyarlılıklarının bilinmesi, ampirik tedavilere yön verebilmek, hekimlerin kontrollü ve akılcı antibiyotik kullanımı konusunda bilinçlenmesini sağlayacaktır
- 2 July 2023
- Published by Journal of Molecular Virology and Immunology in Journal of Molecular Virology and Immunology
A Rare Case of Bacteremia caused by Ochrobactrum anthropi in Patient with Chronic Kidney Failure Treated by Hemodialysis
Ochrobactrum anthropi, previously known as "Achromobacter group Vd", is a gram-negative, non-lactose-fermenting, obligate aerobic, indole-negative, oxidase-positive, urease-positive, motile bacillus. In recent years, it has emerged as a nosocomial infection agent especially in central venous catheters in both immunosuppressed and immunocompromised individuals. In this case report, a 56-year-old female patient who underwent dialysis for two days a week due to chronic kidney failure and had O. anthropi isolated in blood culture samples taken after fever increased is presented. In conclusion, it should be kept in mind that unusual microorganisms such as catheter-related O. anthropi may appear as causative agents in patients undergoing dialysis due to renal failure.
- 2 July 2023
- Published by Journal of Molecular Virology and Immunology in Journal of Molecular Virology and Immunology
A Rare Case of Bacteremia caused by Ochrobactrum anthropi in Patient with Chronic Kidney Failure Treated by Hemodialysis
Ochrobactrum anthropi, previously known as "Achromobacter group Vd", is a gram-negative, non-lactose-fermenting, obligate aerobic, indole-negative, oxidase-positive, urease-positive, motile bacillus. In recent years, it has emerged as a nosocomial infection agent especially in central venous catheters in both immunosuppressed and immunocompromised individuals. In this case report, a 56-year-old female patient who underwent dialysis for two days a week due to chronic kidney failure and had O. anthropi isolated in blood culture samples taken after fever increased is presented. In conclusion, it should be kept in mind that unusual microorganisms such as catheter-related O. anthropi may appear as causative agents in patients undergoing dialysis due to renal failure.
- 1 March 2023
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 17 (6) , 319-324
Relationship Between Disease Severity and Myeloperoxidase in Chronic Viral Hepatitis: A Prospective Study
Aim: To measure serum myeloperoxidase (MPO) levels and to evaluate the relationship between this parameter and histological findings in chronic hepatitis B and C patients. Materials & methods: Thre...
- 1 March 2023
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 17 (6) , 319-324
Relationship Between Disease Severity and Myeloperoxidase in Chronic Viral Hepatitis: A Prospective Study
Aim: To measure serum myeloperoxidase (MPO) levels and to evaluate the relationship between this parameter and histological findings in chronic hepatitis B and C patients. Materials & methods: Thre...
- Open Access
- 31 December 2022
- Published by Bayt Publications in The Turkish Journal of Geriatrics
- Vol. 25 (4) , 585-591
EVALUATION OF PENTRAXIN 3 UTILITY IN PREDICTING MORTALITY IN GERIATRIC PATIENTS WITH COVID-19: A PROSPECTIVE STUDY
Turkish Journal of Geriatrics is the official publication of Turkish Geriatrics Society and is published four times a year. Turkish Journal of Geriatrics is a peer-reviewed journal and is devoted to high standards of scientific rules and publication ethics.
- 31 December 2022
- Published by Bayt Publications in The Turkish Journal of Geriatrics
- Vol. 25 (4) , 585-591
Open AccessEVALUATION OF PENTRAXIN 3 UTILITY IN PREDICTING MORTALITY IN GERIATRIC PATIENTS WITH COVID-19: A PROSPECTIVE STUDY
Turkish Journal of Geriatrics is the official publication of Turkish Geriatrics Society and is published four times a year. Turkish Journal of Geriatrics is a peer-reviewed journal and is devoted to high standards of scientific rules and publication ethics.
- 30 September 2021
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 26 (3) , 460-467
The Importance of Hematological and Demographic Characteristics in the Course of COVID-19 Pneumonia
- 30 September 2021
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 26 (3) , 460-467
The Importance of Hematological and Demographic Characteristics in the Course of COVID-19 Pneumonia
- Open Access
- 1 September 2021
- Published by Galenos Yayinevi in Gulhane Medical Journal
- Vol. 63 (3) , 200-204
Role of tumor necrosis factor-α, interleukin-1β, interleukin-6 in liver inflammation in chronic hepatitis B and chronic hepatitis C
- 1 September 2021
- Published by Galenos Yayinevi in Gulhane Medical Journal
- Vol. 63 (3) , 200-204
Open AccessRole of tumor necrosis factor-α, interleukin-1β, interleukin-6 in liver inflammation in chronic hepatitis B and chronic hepatitis C